SCHEMBL23055100

SCHEMBL23055100

COc1cccc(N2CCN(Cc3ccc(CCC(=O)NO)cc3)CC2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.64
▸ SMN1; SMN2 Q16637 2/20 0.64
▸ ALDH1A1 P00352 1/20 0.64
▸ MAPT P10636 4/20 0.58
▸ TSHR P16473 2/20 0.58
▸ TP53 P04637 2/20 0.58
▸ HSD17B10 Q99714 2/20 0.58
▸ GFER P55789 3/20 0.55
▸ CACNA1G O43497 2/20 0.53
▸ LMNA P02545 2/20 0.53
▸ KMT2A Q03164 3/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ DRD4 P21917 1/20 0.52
▸ HDAC1 Q13547 2/20 0.52
▸ HDAC3 O15379 1/20 0.52
▸ HDAC4 P56524 1/20 0.52
▸ HDAC7 Q8WUI4 1/20 0.52
▸ HDAC2 Q92769 1/20 0.52
▸ HDAC10 Q969S8 1/20 0.52
▸ HDAC11 Q96DB2 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23055097 0.88 MAPT (0.59) KDM4EALDH1A1MAPTHSD17B10GFER
SCHEMBL23054961 0.84 DRD4 (0.59) CACNA1GDRD4HDAC1HDAC3HDAC4
SCHEMBL27459405 0.83 KDM4E (0.64) KDM4ESMN1; SMN2ALDH1A1MAPTTSHR
SCHEMBL8246835 0.81 KDM4E (0.61) KDM4ESMN1; SMN2ALDH1A1MAPTTSHR
SCHEMBL8744966 0.81 KDM4E (0.71) KDM4ESMN1; SMN2ALDH1A1MAPTTSHR
Hydrochloric Acid SCHEMBL8745027 0.80 KDM4E (0.70) KDM4ESMN1; SMN2ALDH1A1MAPTTSHR
Hydrochloric Acid SCHEMBL7251471 0.79 KDM4E (0.65) KDM4ESMN1; SMN2ALDH1A1MAPTTSHR
SCHEMBL23054969 0.79 MAPK1 (0.63) KDM4ESMN1; SMN2LMNADRD4DRD2
Hydrochloric Acid SCHEMBL8745028 0.79 KDM4E (0.68) KDM4ESMN1; SMN2ALDH1A1MAPTTSHR
SCHEMBL6031705 0.79 KDM4E (1.00) KDM4ESMN1; SMN2ALDH1A1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210060014-A1 COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS CERENO SCIENTIFIC AB (SE) 2021-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210060014-A1 COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS HDAC3, HDAC1, HDAC2 KDM4E 330/4885SMN1; SMN2 2901/4885ALDH1A1 3068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback